How Has The Implantable Cardioverter Defibrillators (ICDs) Market Size Evolved In Recent Years?
The implantable cardioverter defibrillators (icds) market has seen considerable growth due to a variety of factors.
• In recent years, the market for implantable cardioverter defibrillators (ICDs) has witnessed significant growth. The market value is projected to increase from $3.76 billion in 2024 to $3.99 billion in 2025, with a compound annual growth rate (CAGR) of 6.0%.
The historical growth can be ascribed to factors such as a rise in cases of sudden cardiac arrest, the inclusion of implantable cardioverter defibrillator as a secondary preventative measure for sudden cardiac arrest, heightened public awareness, aging demographics, supportive government and healthcare organization policies, and expanded accessibility to healthcare.
What Are The Estimated Market Size And Expected Annual Growth Rates For Globa Implantable Cardioverter Defibrillators (ICDs) Market?
The implantable cardioverter defibrillators (icds) market is expected to maintain its strong growth trajectory in upcoming years.
• The market for implantable cardioverter defibrillators (ICDs) is projected to observe robust expansion in the ensuing years, escalating to $4.99 billion by 2029 at a 5.8% compound annual growth rate (CAGR). The anticipated rise in this period can be ascribed to the increased adoption of implantable defibrillators, the escalating demand for individualized cardiac care, the growing incidence of cardiac rhythm disorders, and an increasing demand in developing markets. Prominent trends for the forecast period encompass technological progression, the launch of subcutaneous ICDs which avert the need for transvenous leads, the growing requirement for combined ICD devices equipped with pacemaker functionality, advancement in detection and sensing algorithms, unceasing progress in wireless charging and battery technology, as well as the integration of artificial intelligence (AI) and data analytics in healthcare.
What Are The Primary Growth Drivers In The Implantable Cardioverter Defibrillators (ICDs) Market?
Growth in the implantable cardioverter defibrillators (ICDs) market is predicted to be driven by the increasing incidence of cardiovascular diseases (CVDs). These diseases, which include conditions like heart attacks, strokes, and hypertension, affect the heart and blood vessels and are often the result of factors such as unhealthy diet, lack of exercise, smoking, and genetic predisposition. As the prevalence of cardiovascular diseases rises, largely due to aging populations, unhealthy lifestyles, and increasing rates of risk factors like obesity, diabetes and hypertension, the demand for implantable cardioverter defibrillators (ICDs) is also expected to grow. These devices help control cardiovascular diseases by administering potentially life-saving electrical shocks to restore normal heart rhythm in patients at risk of sudden cardiac arrest. For example, the Australian Institute of Health and Welfare recorded doctor-certified deaths due to coronary heart disease increasing from 14,100 in 2021 to 14,900 in 2022. It is this escalating prevalence of cardiovascular diseases that fuels the expansion of the implantable cardioverter defibrillators (ICDs) market.
What Are The Key Segments Within The Global Implantable Cardioverter Defibrillators (ICDs) Market?
The implantable cardioverter defibrillators (ICDs) market covered in this report is segmented –
1) By Type: Single Chamber Implantable Cardioverter Defibrillators (ICDs), Dual Chamber Implantable Cardioverter Defibrillators (ICDs), Biventricular Devices
2) By Applications: Bradycardia, Tachycardia, Heart Failure, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Single Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Single Chamber ICDs, MRI-Compatible Single Chamber ICDs, Wireless Single Chamber ICDs
2) By Dual Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Dual Chamber ICDs, MRI-Compatible Dual Chamber ICDs, Wireless Dual Chamber ICDs
3) By Biventricular Devices: CRT-D (Cardiac Resynchronization Therapy Defibrillator), CRT-P (Cardiac Resynchronization Therapy Pacemaker), Biventricular ICDs With Advanced Features (Remote Monitoring, Wireless Capabilities)
Pre-Book The Implantable Cardioverter Defibrillators (ICDs) Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Implantable Cardioverter Defibrillators (ICDs) Market?
Major firms in the implantable cardioverter defibrillators (ICDs) market are turning their attention to technological innovations, such as defibrillators with low power consumption, to improve the proficiency of device, extend battery lifespan, and heighten patient comfort. These defibrillators designed for low-current intake administer electrical shocks to the heart while using less power, therefore lengthening battery life and ensuring effective arrhythmias treatment. For example, in October 2023, MicroPort CRM, a medical device company based in France, introduced the ULYS implantable cardioverter defibrillator (ICD) and the INVICTA defibrillation lead in Japan, marking significant progress in the field of cardiac care technology. These tools offer novel characteristics, like lower power consumption for extended battery durability and MRI compatibility, ensuring their suitability for patients requiring imaging procedures. The ULYS ICD is equipped with the PARAD+ arrhythmia discrimination algorithm and AutoMRI functionality, increasing patient safety during MRI examinations. Furthermore, the INVICTA lead demonstrated a 100% implantation success rate and a 97.4% without complication rate in clinical trials, signifying its dependability and efficacy.
Who Are the Key Players in the Implantable Cardioverter Defibrillators (ICDs) Market?
Major companies operating in the implantable cardioverter defibrillators (ICDs) market are include:
• Abbott Laboratories
• Medtronic Inc.
• Koninklijke Philips N.V.
• Boston Scientific Corporation
• ZOLL Medical Corporation
• St. Jude Medical Inc.
• BIOTRONIK SE & Co. KG
• Nihon Kohden Corporation
• Fukuda Denshi Co. Ltd.
• LivaNova PLC
• MicroPort Scientific Corporation
• Japan Lifeline Co. Ltd.
• AtriCure Inc.
• Physio-Control Inc.
• BPL Medical Technologies Private Limited
• Kestra Medical Technologies Inc.
• CU Medical Germany GmbH
• Metrax GmbH
• Intermedics Inc.
• Sorin Group S.p.A.
What are the Regional Insights into the Implantable Cardioverter Defibrillators (ICDs) Market?
North America was the largest region in the implantable cardioverter defibrillators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardioverter defibrillators (ICDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
